314
Participants
Start Date
November 1, 2014
Primary Completion Date
January 1, 2020
Study Completion Date
March 1, 2020
tailored pharmaceutical treatment
Tailored medication is advised in women with inadequate hemodynamic adaptation to pregnancy. Type of medication depends on total peripheral vascular resistance and heart rate. In short, women with a low peripheral vascular resistance in parallel with a high heart rate are advised a betablocker (labetalol), while a vasodilating agent (calcium channel blocker, nifedipine) was advised in women with a high total peripheral vascular resistance in combination with a low heart rate. Women with suboptimal adaptation to pregnancy without an extreme pronounced vascular profile are advised a centrally acting sympatholytic agent (methyldopa).
Maastricht UMC, Maastricht
Maastricht University Medical Center
OTHER